In accordance with the relevant provisions of the "Regulations on the Administration of Narcotic Drugs and Psychotropic Drugs", the State Food and Drug Administration, the Ministry of Public Security, and the National Health Commission decided to adjust the catalog of narcotic drugs and psychotropic drugs. The announcement is as follows:
1. Include Tajilidine in the catalog of narcotic drugs.
2. Include didacini and etomidate (except for pharmaceutical preparations containing etomidate approved for marketing in China) into the Category II psychotropic drugs catalog.
3. Modafinil will be adjusted from the first category of psychotropic drugs to the second category of psychotropic drugs.
This announcement will come into effect on October 1, 2023.
This is an announcement.
State Food and Drug Administration, Ministry of Public Security
National Health Commission
September 6, 2023